Weng Yuanchi, Chen Mengmin, Gemenetzis Georgios, Shi Yusheng, Ying Xiayang, Deng Xiaxing, Peng Chenghong, Jin Jiabin, Shen Baiyong
Department of General Surgery, Pancreatic Disease Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Department of Surgery, Glasgow Royal Infirmary, Glasgow, Scotland, UK.
Hepatobiliary Surg Nutr. 2020 Dec;9(6):759-770. doi: 10.21037/hbsn.2020.03.19.
Total pancreatectomy (TP) is a complex surgical procedure with significant postoperative morbidity. Despite the narrowed range of indications for TP, the introduction of neoadjuvant chemotherapy and the increasing complexity of surgical resections performed in high-volume centers has increased the number of annually performed TPs, especially regarding malignant disease. The introduction of robotic-assisted pancreatic surgery has provided a novel and minimally invasive approach for TP, yet the feasibility of this technique is still unknown. This study assessed the safety and efficacy of robotic-assisted total pancreatectomy (RTP) compared to conventional open total pancreatectomy (OTP).
All patients who underwent TP between March 2015 and July 2019 in a high-volume institution for pancreatic surgery were included in this retrospective study. Clinical data and perioperative outcomes were derived from the prospectively maintained institutional database. A 1:1 propensity score matching (PSM) method was utilized to compare the RTP and OTP cohorts to minimize bias.
A standardized surgical protocol was utilized for RTP following a learning curve of RPD and RDP. The median operative time for patients who underwent RTP was significantly decreased compared to those who underwent OTP [300 (IQR, 250-360) 360 min (IQR, 300-525), P=0.031]. Additionally, resection and spleen-preserving rates were also higher in the RTP cohort. Major 30-day morbidity (Clavien-Dindo > IIIa) and 90-day mortality were similar between the two cohorts. After a median follow-up time of 15 (IQR, 8-24) months, both the RTP and OTP cohorts had a comparable quality of life regarding exocrine and endocrine insufficiency.
RTP appears to be safe and feasible when utilized in high-volume centers for the indicated management of benign and highly selected malignant pancreatic disease. However, further prospective randomized studies are needed to assess the feasibility of this approach.
全胰切除术(TP)是一种复杂的外科手术,术后发病率较高。尽管TP的适应证范围有所缩小,但新辅助化疗的引入以及在大型中心进行的手术切除复杂性增加,使得每年进行的TP数量有所增加,尤其是在恶性疾病方面。机器人辅助胰腺手术的引入为TP提供了一种新颖的微创方法,但其技术可行性仍不明确。本研究评估了机器人辅助全胰切除术(RTP)与传统开放性全胰切除术(OTP)相比的安全性和有效性。
本回顾性研究纳入了2015年3月至2019年7月在一家大型胰腺手术机构接受TP的所有患者。临床数据和围手术期结果来自前瞻性维护的机构数据库。采用1:1倾向评分匹配(PSM)方法比较RTP和OTP队列,以尽量减少偏差。
在RPD和RDP的学习曲线之后,对RTP采用了标准化的手术方案。与接受OTP的患者相比,接受RTP的患者中位手术时间显著缩短[300(四分位间距,250 - 360)对360分钟(四分位间距,300 - 525),P = 0.031]。此外,RTP队列的切除率和保脾率也更高。两个队列的30天主要发病率(Clavien - Dindo > IIIa)和90天死亡率相似。中位随访时间为15(四分位间距,8 - 24)个月后,RTP和OTP队列在外分泌和内分泌功能不全方面的生活质量相当。
在大型中心用于良性和高度选择的恶性胰腺疾病的指定治疗时,RTP似乎是安全可行的。然而,需要进一步的前瞻性随机研究来评估这种方法的可行性。